SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000886163-20-000136
Filing Date
2020-12-10
Accepted
2020-12-10 16:13:02
Documents
17
Period of Report
2020-10-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A lgnd-20201001.htm   iXBRL 8-K/A 37741
2 EX-23.1 lgnd_8-kaxpfenexxexhibit231.htm EX-23.1 3435
3 EX-99.1 lgnd8kapfenexexhibit991.htm EX-99.1 492027
4 EX-99.2 lgnd8kapfenexexhibit992.htm EX-99.2 344795
  Complete submission text file 0000886163-20-000136.txt   1106014

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20201001.xsd EX-101.SCH 2430
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20201001_cal.xml EX-101.CAL 718
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20201001_def.xml EX-101.DEF 1655
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20201001_lab.xml EX-101.LAB 24270
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20201001_pre.xml EX-101.PRE 12654
10 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20201001_htm.xml XML 10788
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 201380700
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences